The investigation of 125I seed implantation as a salvage modality for unresectable pancreatic carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Wang, Hao ^a   Wang, Junjie ^a   Jiang, Yuliang ^a   Li, Jinna ^a   Tian, Suqing ^a   Ran, Weiqiang ^a   Xiu, Dianrong ^a   Gao, Yang ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

125Iseed; Intraoperative implantation; Pancreatic carcinoma; Ultrasound guided; Unresectable

Indexed keywords

GEMCITABINE; IODINE 125; PACLITAXEL; RADIOACTIVE IODINE;

ADJUVANT THERAPY; ADULT; ANALGESIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; DRUG EFFICACY; DRUG IMPLANTATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LAPAROTOMY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PAIN ASSESSMENT; PANCREAS CARCINOMA; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION ENTEROPATHY; SALVAGE THERAPY; STOMACH ULCER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; ECHOGRAPHY; METHODOLOGY; PAIN; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS;

ADULT; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM STAGING; PAIN; PANCREATIC NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84890966184     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-106     Document Type: Article

References (38)

1. Cancer statistics, 2012. Siegel R, Naishadham D, Jemal A, CA Cancer J Clin 2012 62 10 29 10.3322/caac.20138 22237781
2. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA, Ann Surg 1995 221 721 731 10.1097/00000658- 199506000-00011 7794076
3. Pancreaticoduodenectomy with vascular resection for local advanced pancreatic head cancer: a single center retrospective study. Wang C, Wu H, Xiong J, Zhou F, Tao J, Liu T, Zhao G, Gou S, J Gastrointest Surg 2008 12 2183 2190 10.1007/s11605-008-0621-9 18683009
4. Practice guidelines in oncology: pancreatic carcinoma 2012. National Comprehensive Cancer Network, Available at: http://www.nccn.org/professionals/ physician-gls/pdf/pancreatic.pdf
5. Intraoperative and conformal external-beam radiation therapy in patients with locally advanced pancreatic carcinoma, results from a feasibility phase II study. Furuse J, Ogino T, Ryu M, Kinoshita T, Konishi M, Kawano N, Ishikura S, Shimizu W, Sekiguchi R, Moriyama N, Iwasaki M, Yoshino M, Hepatogastroenterology 2000 47 1142 1146 11020899
6. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma. Furuse J, Kinoshita T, Kawashima M, Ishii H, Nagase M, Konishi M, Nakagohri T, Inoue K, Ogino T, Ikeda H, Maru Y, Yoshino M, Cancer 2003 97 1346 1352 10.1002/cncr.11165 12599244 (Pubitemid 36237323)
7. Intraoperative ultrasound-guided iodine-125 seed implantation for unresectable pancreatic carcinoma. Wang JJ, Jiang YL, Li JN, Tian SQ, Ran WQ, Xiu D, J Exp Clin Cancer Res 2009 28 1 6 10.1186/1756-9966-28-1 19126230
8. Reporting results of cancer treatment. Miller AB, Hoogstraten B, Staquet M, Winkler A, Cancer 1981 47 207 214 10.1002/1097-0142(19810101)47:1<207:: AID-CNCR2820470134>3.0.CO;2-6 7459811 (Pubitemid 11167383)
9. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. International Association for the Study of Pain, Subcommittee on Taxonomy, Pain 1986 3 Suppl 221 226
10. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P, Herman JM, Cameron JL, Yeo CJ, Halushka MK, Eshleman JR, Raben M, Klein AP, Hruban RH, Hidalgo M, Laheru D, J Clin Oncol 2009 27 1806 1813 10.1200/JCO.2008.17.7188 19273710
11. Palliative resections versus palliative bypass procedures in pancreatic cancer-a systematic review. Gillen S, Schuster T, Friess H, Kleeff J, Am J Surg 2012 203 496 502 10.1016/j.amjsurg.2011.05.004 21872208
12. The role of radiotherapy in locally advanced pancreatic carcinoma. Gutt R, Liauw SL, Weichselbaum RR, Nat Rev Gastroenterol Hepatol 2010 7 437 447 10.1038/nrgastro.2010.98 20628346
13. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group, J Natl Cancer Inst 1988 80 751 755 2898536
14. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. Chauffert B, Mornex F, Bonnetain F, Rougier P, Mariette C, Bouche O, Bosset J, Aparicio T, Mineur L, Azzedine A, Hammel P, Butel J, Stremsdoerfer N, Maingon P, Bedenne L, Ann Oncol 2008 19 1592 1599 10.1093/annonc/mdn281 18467316
15. A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201 [abstract]. Loehrer PJ, Powell ME, Cardenes HR, Wagner L, Brell JM, Ramanathan RK, Crane CH, J Clin Oncol 2008 26 4506
16. A randomized phase II study of gemcitabine 1000 mg/msq and concurrent radiotherapy comparing gemcitabine alone for unresectable locally advanced pancreatic adenocarcinoma [abstract]. Ioka T, Nakamura S, Nishiyama K, Int J Radiat Oncol Biol Phys 2010 78 102
17. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Hoyer M, Roed H, Sengelov L, Traberg A, Ohlhuis L, Pedersen J, Nellemann H, Berthelsen A, Eberholst F, Engelholm SA, von der Maase H, Radiother Oncol 2005 76 48 53 10.1016/j.radonc.2004.12.022 15990186 (Pubitemid 41096514)
18. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Mahadevan A, Jain S, Goldstein M, Miksad R, Pleskow D, Sawhney M, Brennan D, Callery M, Vollmer C, Int J Radiat Oncol Biol Phys 2010 78 735 742 10.1016/j.ijrobp.2009.08.046 20171803
19. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Schellenberg D, Kim J, Christman-Skieller C, Chun CL, Columbo LA, Ford JM, Fisher GA, Kunz PL, Van Dam J, Quon A, Desser TS, Norton J, Hsu A, Maxim PG, Xing L, Goodman KA, Chang DT, Koong AC, Int J Radiat Oncol Biol Phys 2011 81 181 188 10.1016/j.ijrobp.2010.05.006 21549517
20. Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration. Polistina F, Costantin G, Casamassima F, Francescon P, Guglielmi R, Panizzoni G, Febbraro A, Ambrosino G, Ann Surg Oncol 2010 17 2092 2101 10.1245/s10434-010-1019-y 20224860
21. Prognostic implications of intraoperative radiotherapy for unresectable pancreatic cancer. Nagai S, Fujii T, Kodera Y, Kanda M, Sahin TT, Kanzaki A, Yamada S, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakao A, Pancreatology 2011 11 68 75 10.1159/000324682 21525774
22. Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Ogo E, Etoh H, Kazumoto T, Takayama M, Nemoto K, Nishimura Y, Int J Radiat Oncol Biol Phys 2011 80 111 118 10.1016/j.ijrobp.2010.01.065 20598450
23. 3D-Ct-planned interstitial HDR brachytherapy + percutaneous irradiation and chemotherapy in inoperable pancreatic carcinoma. Methods and clinical outcome. Pfreundner L, Baier K, Schwab F, Willner J, Bratengeier K, Flentje M, Feustel H, Fuchs KH, Strahlenther Onkol 1998 174 133 141 10.1007/BF03038496 9524622
24. The direct biologic effects of radioactive §ssup§125§ esup§I seeds on pancreatic cancer cells PANC-1, at continuous low-dose rates. Wang J, Wang J, Liao A, Zhuang H, Zhao Y, Cancer Biother Radiopharm 2009 24 409 416 10.1089/cbr.2008.0563 19694575
25. Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth. Ma J, Jin Z, Si P, Liu Y, Lu Z, Wu H, Pan X, Wang L, Gong Y, Gao J, Li Z, J Exp Clin Cancer Res 2011 30 35 46 10.1186/1756-9966-30-35 21457568
26. Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression. Gao J, Wang L, Xu J, Zheng J, Man X, Wu H, Jin J, Wang K, Xiao H, Li S, Li Z, J Exp Clin Cancer Res 2013 32 86 95 10.1186/1756-9966-32-86
27. §ssup§125§esup§I seed irradiation induces up-regulation of the genes associated with apoptosis and cell cycle arrest and inhibits growth of gastric cancer xenografts. Ma Z, Yang Y, Zou L, Luo K, J Exp Clin Cancer Res 2012 31 61 70 10.1186/1756-9966-31-61 22827957
28. The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells. Zhuang H, Wang J, Liao A, Wang J, Zhao Y, J Exp Clin Cancer Res 2009 28 12 10 10.1186/1756-9966-28-12 19175942
29. Iodine-125 implant and external beam irradiation in patients with localized pancreatic carcinoma: a comparative study to surgical resection. Shipley WU, Nardi GL, Cohen AM, Ling CC, Cancer 1980 45 709 714 10.1002/1097-0142(19800215)45:4<709::AID-CNCR2820450416>3.0.CO;2-5 6244074 (Pubitemid 10174613)
30. Pancreatic cancer and its treatment by implanted radium. Handley WS, Ann Surg 1934 100 215 223 10.1097/00000658-193407000-00021 17856333
31. Cancer of the Pancreas. Hilaris BS, Roussis K, Handbook of Radiotherapy Brachytherapy American National Cancer Institute, Acton Mass Publishing Sciences Group, Hilaris BS, 1975 251 262
32. Comparison of conventional surgical resection, radioactive implantation, and bypass procedures for exocrine carcinoma of the pancreas 1975-1980. Morrow M, Hilaris B, Brennan MF, Ann Surg 1984 199 1 5 10.1097/00000658-198401000-00001 6419687 (Pubitemid 14218866)
33. Interstitial iodine-125 implant in the management of unresectable pancreatic carcinoma. Syed AM, Puthawala AA, Neblett DL, Cancer 1983 52 808 813 10.1002/1097-0142(19830901)52:5<808::AID-CNCR2820520510>3.0.CO;2-U 6191854 (Pubitemid 13037642)
34. Treatment of primary unresectable carcinoma of the pancreas with I-125 implantation. Peretz T, Nori D, Hilaris B, Manolatos S, Linares L, Harrison L, Anderson LL, Fuks Z, Brennan MF, Int J Radiat Oncol Biol Phys 1989 17 931 935 10.1016/0360-3016(89)90138-7 2808054 (Pubitemid 19279494)
35. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma. Ishii H, Okada S, Tokuuye K, Nose H, Okusaka T, Yoshimori M, Nagahama H, Sumi M, Kagami Y, Ikeda H, Cancer 1997 79 1516 1520 10.1002/(SICI)1097-0142(19970415)79:8<1516::AID- CNCR11>3.0.CO;2-0 9118032 (Pubitemid 27154781)
36. Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: Results of a feasibility study. Andre T, Balosso J, Louvet C, Hannoun L, Houry S, Huguier M, Colonna M, Lotz JP, De Gramont A, Bellaïche A, Parc R, Touboul E, Izrael V, Int J Radiat Oncol Biol Phys 2000 46 903 911 10.1016/S0360-3016(99)00478-2 10705012 (Pubitemid 30114403)
37. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin. Kornek GV, Schratter-Sehn A, Marczell A, Depisch D, Karner J, Krauss G, Haider K, Kwasny W, Locker G, Scheithauer W, Br J Cancer 2000 82 98 103 10638974 (Pubitemid 30008966)
38. Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma. Boz G, De Paoli A, Innocente R, Rossi C, Tosolini G, Pederzoli P, Talamini R, Trovò MG, Int J Radiat Oncol Biol Phys 2001 51 736 740 10.1016/S0360-3016(01)01708-4 11597816